InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: None

Wednesday, 06/21/2017 10:20:15 AM

Wednesday, June 21, 2017 10:20:15 AM

Post# of 345989
Well, well, well, what do we have here?

Who is Ronin's John Stafford III?

John Stafford, III has notified the company of his decision to resign effective January 5, 2016 from the Board of Directors after 18 years of service to the company.

"John was the original lead investor in Xencor and continues his unwavering support of the company to this day," said Bassil Dahiyat, Ph.D., president and chief executive officer of Xencor. "His leadership has been instrumental to our success and growth, and I thank him both personally and on behalf of the entire company for his contributions."

"Xencor has established itself as a leading antibody drug development company, and it has been exciting to be a part of this growth over the years as the company took its powerful technology platform and developed a deep pipeline of better antibody drug candidates," said Mr. Stafford. "I will continue to be tremendously supportive of Xencor and intend to follow its milestones closely.



So let's see. Good ol' JS III spends 18 years dedicated to a monoclonal Ab firm and was the original LEAD investor. Now ol' Johnny throws tens of millions at PPHM.

Nothing to see here, folks, move along now. Sell those shares, please.

Best,

Joe Six Pack
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News